<DOC>
	<DOCNO>NCT00308737</DOCNO>
	<brief_summary>Pulmonary Safety Diabetics T/I</brief_summary>
	<brief_title>Safety Inhaled Insulin With Type 1 Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>For All Subjects : Nonsmoking Body mass index &lt; 42 kg/m2 FEV1 great equal 70 % predict , DLco TLC great equal 80 % predict screening , No abnormalities screen pulmonary radiology For Subjects diabetes mellitus : Type 1 type 2 diabetes least 2 year HbA1c great equal 6.6 % less equal 12.0 % For Subjects without abnormality glucose control : No history diabetes Normal result formal glucose tolerance test History chronic obstructive pulmonary disease , asthma , significant pulmonary disease Significant renal , hepatic , cardiac disease Women pregnant , lactate , plan become pregnant Subjects participate study investigational drug within previous 3 month Evidence severe complication diabetes</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>